logo

Video encyclopedia

Niraparib

1:00:04

Combinatorial Drug Screening - Module 6, Session 4

1:03:26

Clinical Trials for Female Cancers

Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.